BioCentury
ARTICLE | Company News

Myriad Genetics, Laboratory Corp. of America Holdings sales and marketing update

December 10, 2001 8:00 AM UTC

MYGN granted LH exclusive sales and distribution rights to MYGN's predictive medicine products. For an upfront fee, LH will receive the right to market to primary care physicians MYGN's BRACAnalysis,...